Funding Amount

Varies

Deadline

Rolling / Open

Grant Type

foundation

Overview

Senior Investigator Awards

Overview: Lynn Sage Scholar research grants that fund experienced researchers exploring breakthrough approaches that could transform the field of breast cancer research.

Focus Areas:

  • Breast cancer risk prediction using artificial intelligence and genetic markers

  • Family planning and hormonal contraceptive interactions with breast cancer prevention medications

  • Mitochondrial dysfunction and metastasis prevention

  • Immunotherapy resistance in triple negative breast cancer

  • Tumor-promoting neutrophils and immunotherapy enhancement

  • Cancer prevention and treatment innovations
  • Geographic Scope: Chicago-area based researchers, though investments drive impact globally

    Eligibility: Senior/experienced researchers at academic institutions (professors, associate professors)

    Current Investigators Include:

  • Dezheng Huo, PhD, University of Chicago

  • Dr. Seema Khan, Northwestern University Feinberg School of Medicine

  • Kay F. Macleod, PhD, University of Chicago

  • Amanda L. Marzo, PhD, Rush University Medical Center

  • Bin Zhang, MD, PhD, Northwestern University Feinberg School of Medicine
  • Past Investigators Include:

  • Dr. Jun Huang, UChicago Pritzker School of Molecular Engineering

  • Dr. Jaehyuk Choi, Northwestern University Feinberg School of Medicine

  • Deyu Fang, PhD, Northwestern University Feinberg School of Medicine

  • Ann Marie Flores, PT, PhD, Northwestern University Feinberg School of Medicine
  • Seed Funding: Every grant provides vital seed funding, empowering researchers to gather critical data and unlock larger support from major funders like the National Institutes of Health

    Organization: Lynn Sage Breast Cancer Foundation

    Contact:

  • Phone: 312.252.2502

  • Email: info@lynnsage.org

  • Address: 3023 N. Clark Street Suite 139, Chicago, IL 60657
  • Background: Lynn Sage was an early investor in the study of Tamoxifen, which is now the standard of care treatment for hormone-receptor-positive breast cancer. 94% of funds raised go to research & education.

    Focus Areas & Funding Uses

    Fields of Work

    cancerscience-research

    Categories

    Browse similar grants by category

    Related Grants

    Similar grants from this funder and related organizations

    Ready to apply for Senior Investigator Awards?

    Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.